InvestorsHub Logo
Followers 230
Posts 14589
Boards Moderated 1
Alias Born 03/29/2014

Re: biosectinvestor post# 289182

Saturday, 06/13/2020 2:02:17 PM

Saturday, June 13, 2020 2:02:17 PM

Post# of 690938
I know the person who recommended that this person get into the trial. In fact, there were three pancreatic cancer patients at MD Anderson who this person knew at the time who they encouraged to enter the trial. Alan Butler was the only one who did. Unfortunately, the other two people died rather quickly, within 3 to 6 months.

I don't think the video was what Dr. Buzdar took exception with, although you are correct in that Dr. Buzdar had absolutely nothing to do with the trial at all. It was Dr. Vivek Subbiah's trial.
https://twitter.com/VivekSubbiah

Perhaps the video played some sort of minor role, but it was never mentioned in The Street article Adam wrote. Buzdar's complaints were primarily regarding the press releases that the company had put out regarding "an early peak" from the open label, Phase 1 Direct trial.
The Street article
https://www.thestreet.com/investing/stocks/prestigious-cancer-hospital-rebukes-northwest-bio-for-inappropriate-data-disclosures-12749366
NWBO PRs regarding early Direct results (I encourage reading them, if you haven't)
https://nwbio.com/nw-bio-announces-first-data-from-ongoing-dcvax-direct-trial/
https://nwbio.com/early-positive-responses-seen-in-over-50-of-dcvax-direct-patients-to-date/

This is much like what Adam wrote six years later with the Remdesiver trial data in his April 16, 2020 Stat article linked here... lol.
https://www.statnews.com/2020/04/16/early-peek-at-data-on-gilead-coronavirus-drug-suggests-patients-are-responding-to-treatment/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News